A comparison of the differentially expressed features between newly diagnosed RRMS patients and T1 and T10 showed that the ceramides C16 ceramide, Cer(D18:2/16:0), and CerPE(d16:2(4E,6E)/22:0) were significantly increased in concentration after transplantation. The gene discussed is CBLN1; the disease is relapsing-remitting multiple sclerosis.